BioScience

BIND Biosciences subleases space

The Boston Business Journal (Free subscription) | yesterday

BIND Biosciences Inc. subleased 26,148 square feet from Alkermes Inc. at 64 Sidney St. in University Park at MIT in Cambridge.

DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product

Business Wire (Free subscription) | yesterday

LANSING, Mich.--(BUSINESS WIRE)--DuPont Applied BioSciences has turned to MBI International to join the DuPont team in evaluating the commercial viability of an important bio-based product line. MBI International is a

Arcadia Biosciences Receives $3.6 Million USAID Grant to Develop Improved Crops in India

Business Wire (Free subscription) | yesterday

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that it

Meridian Bioscience Announces Filing of Shelf Registration Statement to Replace Expiring Registration Statement

Business Wire (Free subscription) | yesterday

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has filed a shelf registration statement on Form S-3 with the US Securities and Exchange Commission. This

Helicos BioSciences Corporation Realigns Senior Management Team

Business Wire (Free subscription) | yesterday

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences (NASDAQ:HLCS) announced today that its Board of Directors has appointed Ronald Lowy as the company’s Chief Executive Officer, effective immediately. Ron has

ImmuneRegen BioSciences, Inc.: ImmuneRegen(R) Appoints Wound Healing and Tissue Regeneration Expert Spencer A. Brown, Ph.D. to Advisory Board

Market Wire (Free subscription) | 01/12/2008

SCOTTSDALE, AZ (MARKET WIRE) ImmuneRegen(R) BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), announced today that it appointed Spencer A. Brown, Ph.D., to its advisory board. Dr. Brown, who has more than 20 years experience as a clinical researcher and biotech company entrepreneur and advisor, is director of research of the plastic surgery department...

BioScience tip sheet, December 2008

Eurekalert (Free subscription) | 01/12/2008

A listing and short description of the peer-reviewed articles in the December 2008 issue of BioScience.

Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008

PR News Wire (Free subscription) | 01/12/2008

Regado Biosciences is pioneering a new therapeutic field with the creation and development of two-component drug systems, comprising an aptamer therapeutic that can be controlled directly by its specific and matched reversal agent. Regado's technology is designed to give physicians the ability to directly control and titrate each system's therapeutic effect. Enhanced control and flexibility...

PURE Bioscience and Ciba Strike New Contract for Natural Antimicrobial

PR News Wire (Free subscription) | 01/12/2008

Krall concluded, "As government agencies institute stricter policies on chemical use, corporations face mounting pressure to protect human health and the environment. At the same time, commercial and retail consumers are increasingly discriminating about ingredients in the products they purchase. Accordingly, many antimicrobial chemicals are under intense scrutiny. Our technology addresses these significant...

Aura Biosciences moves in!

Martin Varsavsky (Free subscription) | 01/12/2008

I am pleased to announce that Aura Biosciences a US/Spanish biotech company that is developing ground breaking nanotechnology for the targeted delivery of drugs has moved to the offices of Jazzya, my holding company. The company was founded by my former student Elisabet de los Pinos and has developed the Nanotsmart Technology. Aura joins [...]

Lux Biosciences Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for LUVENIQ™

Business Wire (Free subscription) | 26/11/2008

JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences today announced that the Pediatric Committee of the European Medicines Agency (EMEA) has issued a positive opinion on Lux’s Pediatric Investigation Plan (PIP)

Abraxis BioScience to Re-Acquire U.S. Abraxane Rights

Contract Pharma Breaking News (Free subscription) | 25/11/2008

Abraxis BioScience, Inc. has entered into an agreement with AstraZeneca UK Ltd. , under which Abraxis would re-acquire the exclusive rights to market Abraxane (paclitaxel protein-bound particles for injectable suspension) in the U.S. The agreement is subject to approval by the board of directors of Abraxis. “We believe the time has come to further build our commercialization platform for Abraxane...

• Abraxis BioScience Announces Agreement to Re-Acquire Exclusive U.S. Rights to ABRAXANE; Company Highlights Plans to Initiate Nine Pivotal Registrational Trials in 2009 - Business Wire

Abraxis BioScience Announces Agreement to Re-Acquire Exclusive U.S. Rights to ABRAXANE; Company Highlights Plans to Initiate Nine Pivotal Registrational Trials in 2009

Business Wire (Free subscription) | 25/11/2008

LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced today that the company has entered into an agreement with AstraZeneca UK Limited, under

Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer

PR News Wire (Free subscription) | yesterday

Regado Biosciences is pioneering a new therapeutic field with the creation and development of two-component drug systems, comprising an aptamer therapeutic that can be controlled directly by its specific and matched reversal agent. Regado's technology is designed to give physicians the ability to directly control and titrate each system's therapeutic effect. Enhanced control and flexibility...

Arcadia gets $3.6M grant to develop crops in India

The Sacramento Business Journal (Free subscription) | yesterday

Arcadia Biosciences Inc. has received a $3.6 million grant to develop rice and wheat in India that use less fertilizer and water.

• Arcadia Biosciences Receives $3.6 Million USAID Grant to Develop Improved Crops in India - Business Wire